*Refresh the page if the below document does not appear.
CDSCO grants approval to manufacture and market Progesterone SR Tablet
Pharma giant Sun Pharma received a nod from the SEC (Subject Expert Committee) under the CDSCO (Central Drug Standard Control Organization) for the manufacturing and marketing of the Progesterone Sustained Release (SR) tablets of 200,300,and 400mg strengths.
Marksans pharma acquires Israeli drugmaker Teva's manufacturing facility in Goa
The Mumbai-based company did not disclose the amount involved in the acquisition and has agreed to retain the site employees with no changes in the terms of employment. The manufacturing unit is spread across 47,597 metres and has approvals from EU, Health Canada, and Japanese Health Authority.
1.5 Lakh antibiotics and thousands alcoholism treatment drug recalled as samples fail test
Chandigarh’s drug control department conducted tests for 10 drug samples out of which 50% failed to pass the test. More than 1.5 Lakh antibiotics were found to have no content of medicine and thousands of alcohol addiction treatment drugs were found to be spurious and substandard.
Multiple violations found at Maiden Pharma's Sonepat facility
A preliminary report revealed the presence of multiple faults at the Maiden Pharma’s Sonepat facility. The people from state drug regulatory authority mentioned that details about the results were reported by the investigator to the union health minister on Tuesday.
Zydus' stocks experiences an 8-month high after Back-to-back approvals from US FDA
The company’s stock has gained 10% over the past five sessions after getting four approvals from US FDA in a week. In a total, it has a whopping 326 approvals from 428 ANDAs (Abbreviated New Drug Applications) filed since June 30, 2022.
NIPER gets patent granted for its invention of new Anti-TB compound
The IPO (Indian Patent Office) has granted a patent filed by NIPER (National Institute of Pharmaceutical Education and Research), Mohali for a new compound mentioned as an anti-tubercular agent along with an improved process of preparation for it which is beneficial to meet the imperfections of the existing drugs.
PharmNXT launches first integrated manufacturing facility in Pune
In allignment with the “Make in India”
programme, the Mumbai-based company
launched an integrated manufacturing unit for
single use bioprocessing solutions. The facility is
named ‘PharmNXT ekuse’ and has an area of
over 40,000 sq.ft.
